JUL 21, 2020 7:35 AM PDT

New Drug Discoveries are Due To Good Labs

WRITTEN BY: Nouran Amin

A study suggests that the quality of lab procedures performed heavily influences the rate of drug discoveries. These findings were due to a statistical measure known as the "Z' value" and were published in the Journal of Medicinal Chemistry. 

"There are a lot of diseases out there for which there is no treatment or the treatments aren't very good," said Dr Matthew Lloyd, who led the study from the University's Department of Pharmacy and Pharmacology. "This explains why there is such a big drive to develop new treatments using high-throughput screening." 

The results can potentially pressurize labs on revolutionizing their practices in order to speed drug discovery. 

"These findings underline how important it is to make sure your assay is the best possible quality it can be," said Dr Lloyd. "A high Z' factor, indicative of high-quality lab procedures, enables more hits to be found and ultimately should increase the chances of new treatments being developed. 

"Some studies are currently using assays that are not very good in terms of the Z'-factor. It was thought that 0.5 was acceptable but this review shows a level between 0.75 and 0.8 is the minimum that should be aimed for. 

Learn more about drug discovery in the lab: 

 

"I suspect some researchers don't realize there is such a pronounced effect, which is why they settle for assay with a Z' of 0.7. But in the future, people in industry will need to be mindful of the results.” 

Source: Science Daily  

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 12, 2020
Technology
The Crossover of Virtual Reality and Drug Discovery
NOV 12, 2020
The Crossover of Virtual Reality and Drug Discovery
Researchers have recently developed a unique virtual reality (VR) tool that can help in drug development? Particularly, ...
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 10, 2020
Immunology
Drug Turns Back the Clock in Aged Brains
DEC 10, 2020
Drug Turns Back the Clock in Aged Brains
When faced with stressful stimuli — anything from oxygen or nutrient deprivation to viral infections — cells ...
DEC 25, 2020
Drug Discovery & Development
Class of Antibiotics May Target Resistant Bacteria
DEC 25, 2020
Class of Antibiotics May Target Resistant Bacteria
Researchers found a new class of antibiotics for combatting antimicrobial resistance (AMR). Learn more about antibiotic ...
JAN 19, 2021
Immunology
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
JAN 19, 2021
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
Milk, eggs, peanuts, tree nuts, wheat, soy, fish, and shellfish—these foods are among the most unwanted list for t ...
Loading Comments...